Cargando…
Comprehensive phenotyping and biological marker discovery
There is an enormous unmet need for biological markers to characterize disease type, status, progression, and response to therapy. We are developing and applying an integrated bioanalytical platform and clinical research program to facilitate comprehensive differential phenotyping of patient samples...
Autor principal: | Kantor, Aaron B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851087/ https://www.ncbi.nlm.nih.gov/pubmed/12364815 http://dx.doi.org/10.1155/2002/178798 |
Ejemplares similares
-
Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
por: O’Connor, Kevin C., et al.
Publicado: (2006) -
Systems Biology Approaches to Disease Marker Discovery
por: Sharon, Donald, et al.
Publicado: (2010) -
Systems Biology and the Discovery of Diagnostic Biomarkers
por: Wang, Kai, et al.
Publicado: (2010) -
A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma
por: Steel, Laura F., et al.
Publicado: (2001) -
Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review
por: Terry, Kathryn L., et al.
Publicado: (2004)